Qian Liu

3PUBLICATIONS
2CO-AUTHORS
Metabolic medicineHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jan 10, 2026
MSDC-0160, a novel clinical-stage mitochondrial pyruvate carrier inhibitor, suppresses osteoclast differentiation and alleviates type 2 diabetes-related bone loss.

Chaofeng Wang, Na Hai, Liuyuan Chen

|Aug 04, 2024
Trifolirhizin reduces osteoclast formation and prevents inflammatory osteolysis by inhibiting RANKL-induced activation of NF-κB and MAPK signaling pathways and ROS.

Jian Huang, Dezhi Song, Minglian Xu

|Feb 15, 2024
Cichoric acid targets RANKL to inhibit osteoclastogenesis and prevent ovariectomy-induced bone loss.

Yansi Xian, Yijie Gao, Yiji Su

Pageof 1

Frequent Collaborators

1 joint publications

Fangming Song

1 joint publications

Jiake Xu